Back

Finerenone vs spironolactone: comparative effectiveness and safety in patients with HFpEF and chronic kidney disease

30 August 2026 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Exploring the peripheries in HFpEF Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Jacob Hicks

Emory Healthcare, Atlanta (United States of America)

5 More presentations in this session

Presentation thumbnail
Non-invasive pulse-wave-analysis for screening of HFpEF in at-risk patients: findings from the ARTS-PREDICTION study
Doctor J. Gronwald (Goettingen, DE)
Abstract Slides Video
Presentation thumbnail
Incremental risk stratification using the H2FPEF score in patients with chronic kidney disease and unexplained dyspnea
Mr A. Al-Rubai (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Prevalence and reclassification of monoclonal gammopathy in elderly HFpEF patients undergoing ATTR-CM screening: A PATCH-HFpEF sub-study
Doctor P. Liao (TW)
Abstract Slides Video
Presentation thumbnail
Diagnostic performance of the H₂FPEF score and cardiovascular burden in patients with chronic kidney disease: a cross-sectional study
Doctor M. Covic (Iasi, RO)
Abstract Slides Video
Presentation thumbnail
Indoxyl sulfate (IS)-CTSK axis mediates cardiac fibroblast activation in CKD-Related HFpEF
Doctor Y. Zou (Shanghai, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Exploring the peripheries in HFpEF

The Event

Event poster

ESC Congress 2026

30 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Finerenone: from evidence to clinical practice. Data from the finerlife registry (finerenone in real life)
10 May 2026
thumbnail
Congress Presentation
Impact of renin-angiotensin system inhibitors in patients with heart failure with reduced ejection fraction and advanced chronic kidney disease
29 August 2026
thumbnail
Congress Presentation
The effectiveness of eplerenone vs spironolactone on left ventricular systolic function, hospitalization and cardiovascular death in patients with chronic heart failure - HFrEF
27 August 2023
thumbnail
Congress Presentation
Finerenone in patients with heart failure and diabetic kidney disease: comparison of mineralocorticoid receptor antagonists. FINARM study
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources